Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-4-8
|
pubmed:abstractText |
A study was made of the in vitro effects of recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on breast, prostate, cervix and colon cancers. Tumour growth was assessed using a soft agar clonogenic assay. Stimulation of megakaryocyte numbers was seen in liquid culture following 10 ng/ml PEG-rHuMGDF. The same concentration led to no significant difference in colony-forming efficiencies for 22 of 25 tumour samples. A significant reduction in colony-forming efficiencies was seen for the remaining 3 specimens. These results suggest that PEG-rHuMGDF will not stimulate tumour growth in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0030-2414
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9075786-Breast Neoplasms,
pubmed-meshheading:9075786-Cell Division,
pubmed-meshheading:9075786-Clone Cells,
pubmed-meshheading:9075786-Colonic Neoplasms,
pubmed-meshheading:9075786-Female,
pubmed-meshheading:9075786-Humans,
pubmed-meshheading:9075786-Male,
pubmed-meshheading:9075786-Megakaryocytes,
pubmed-meshheading:9075786-Neoplasms,
pubmed-meshheading:9075786-Polyethylene Glycols,
pubmed-meshheading:9075786-Prostatic Neoplasms,
pubmed-meshheading:9075786-Recombinant Proteins,
pubmed-meshheading:9075786-Thrombopoietin,
pubmed-meshheading:9075786-Tumor Cells, Cultured,
pubmed-meshheading:9075786-Uterine Cervical Neoplasms
|
pubmed:articleTitle |
In vitro effects of recombinant human megakaryocyte growth and development factor on primary human tumour colony growth.
|
pubmed:affiliation |
CRC Department of Experimental Haematology, Christie Hospital, Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|